[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616462":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":24,"locations":35,"responsibleParty":52,"collaborators":57,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":10,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":77,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Region Stockholm","OTHER_GOV",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage",null,[12,13],"Drug: Induced hypertension with norepinephrine","Drug: Endoluminal Spasmolysis",[15,20],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DRUG","Induced hypertension with norepinephrine","Induced hypertension with norepinephrine and\u002For dobutamine to attain clinically established goals of cerebral perfusion pressure in a stepwise fashion, according to clinical routine.",[9],{"type":16,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Endoluminal Spasmolysis","Endoluminal spasmolysis of cerebral arteries using i.a. Nimodipine, according to clinical protocol and neurointerventionist discretion.",[9],[25,31],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Peter C Rudberg, M.D. Ph.D.","CONTACT","+46-8-12370000","72341","peter.rudberg@ki.se",{"name":32,"role":27,"phone":28,"phoneExt":33,"email":34},"Anja Rosén, M.D.","94856","anja.rosen@ki.se",[36],{"facility":37,"status":38,"city":39,"state":10,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Karolinska University Hospital","RECRUITING","Stockholm","17176","Sweden","SE",{"type":44,"coordinates":45},"Point",[46,47],18.06871,59.32938,{"lat":47,"lon":46},[50],{"name":51,"role":27,"phone":28,"phoneExt":29,"email":30},"Peter C Rudberg, M.D Ph.D.",{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":56,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Peter Rudberg","Senior Consultant, Research Group Leader","Karolinska Institutet",[58],{"name":56,"class":59},"OTHER","100616462","delayed-cerebral-infarction-beyond-endoluminal-spasmolysis-and-induced-hypertension-100616462",false,"NCT07305922","Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension","Decibel","Inclusion Criteria:\n\n* Adults 18 years or older\n* Critical care after subarachnoid haemorrhage\n* Aneurysm secured by surgical clipping or endovascular procedure\n* Suspected, emerging or established severe cerebral vasospasm\n\nExclusion Criteria:\n\n* Anticipated survival less than five days, as determined by treating clinician\n* Transcranial Doppler signal too weak\n* Pregnancy","ALL","18 Years",{"count":70,"type":71},200,"ESTIMATED","OBSERVATIONAL","An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.",[75,76],"Subarachnoid Aneurysm Hemorrhage","Cerebral Vasospasm After Subarachnoid Hemorrhage",[78,21,79,80],"Transcranial Doppler","Induced Hypertension","Multimodal Neuromonitoring","2025-12-18",{"date":83,"type":84},"2025-12-26","ACTUAL",{"date":86,"type":84},"2025-12-01",{"date":88,"type":71},"2030-12-31",{"name":5,"class":6},1]